Evidence map›Paper›PMID 37315497›Full record

ArticleInternational journal of surgery case reports2023

Solitary fibrous tumor of the breast: A case report.

Chikako Hirose, Tetsu Hayashida, Junichi Saito, Akiharu Kubo, Shuji Mikami, Hiromitsu Jinno

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Chikako HiroseDepartment of Surgery, Inagi Municipal Hospital, Tokyo, Japan. Electronic address: chikakohirose5@gmail.com.
Tetsu HayashidaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan. Electronic address: tetsu@z7.keio.jp.
Junichi SaitoDepartment of Surgery, Inagi Municipal Hospital, Tokyo, Japan. Electronic address: machen@kkd.biglobe.ne.jp.
Akiharu KuboDepartment of Dermatology, Keio University School of Medicine, Tokyo, Japan. Electronic address: akiharu@keio.jp.
Shuji MikamiDepartment of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan. Electronic address: mikamishuji@gmail.com.
Hiromitsu JinnoDepartment of Surgery, Teikyo University School of Medicine, Tokyo, Japan. Electronic address: jinno@med.teikyo-u.ac.jp.
Keio University · JPKeio University Hospital · JPNaga Municipal Hospital · JPSoka Municipal Hospital · JPTeikyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSolitary fibrous tumors (SFTs) are uncommon mesenchymal neoplasms that comprise <2 % of all soft tissue tumors. They are a diagnostically challenging group of neoplasms that can occur essentially anywhere. Molecular or genetic testing of soft tissue tumors will increasingly add to the foundation of distinctive histologic features, as accurate diagnosis is critical for appropriate treatment. CASE PRESENTATION: A 28-year-old woman was referred to our hospital for a left breast mass. Ultrasonography showed an oval hypoechoic mass with partially obscured boundaries. Surgical specimens revealed spindle tumor cells surrounding the mammary ducts and were immunoreactive for both CD34 and STAT6, suggesting SFTs. However, the infiltration of spindle tumor cells into the surrounding fat, and the storiform-like pattern made us consider dermatofibrosarcoma protuberans (DFSP) as a differential diagnosis. Lack of amplification of the COL1A1-PDGFB fusion gene, a characteristic feature of DFSP, led to our definitive diagnosis of breast SFT. DISCUSSION: The presence of STAT6 in tumor cell nuclei is a highly sensitive immunohistochemical marker for SFT. In our case, morphological features evoked the differential diagnosis of DFSP and we investigated the COL1A1-PDGFB fusion gene. The diagnostic process of reliably performing careful morphological examination and immunohistochemical marker test, and then obtain conviction by molecular cytogenetic technique is more and more important for soft tissue tumors.

conclusionsWe report a quite uncommon case of breast SFT and excluded DFSP as a differential diagnosis. If it is difficult to distinguish between these diseases, molecular cytogenetic analysis would be required for accurate diagnosis.

Indexed as

BreastCOL1A1-PDGFB fusion geneDermatofibrosarcoma protuberansSoft tissue tumorSolitary fibrous tumorSTAT6

Identifiers

PMID37315497
PMCPMC10382724
OpenAlexW4379057142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.